Navigation Links
China-Biotics, Inc. Reports First Quarter 2009 Financial Results
Date:8/14/2008

rded in the first quarter of 2009 related to the change in the fair value of the $25 million convertible notes issued in December 2007.

Net income for the first quarter of the 2009 fiscal year was $3.2 million. Excluding the $1.2 million loss on the revaluation of the convertible notes, net income was $4.5 million, up from $3.5 million in the same quarter of the prior year.

Diluted earnings per share were $0.23 calculated on a weighted average basis, compared with $0.21 per diluted share in the first quarter of fiscal 2008. The calculation of diluted earnings per share for the first quarter of 2008 assumes full conversion of the convertible notes and thus excludes the loss from the change in fair value of the notes.

Financial Condition

As of June 30, 2008, the Company had cash and cash equivalents of $66.2 million and working capital of $50.7 million. The increase in cash resulted in part from the private placement of $25 million of the Company's convertible notes in December 2007. In the first quarter of 2009, China-Biotics generated $8.3 million in cash flow from operations and recorded $7.2 million in capital expenditures related to the construction of the new manufacturing facility. Accounts receivable declined to $10.7 million from $13.2 million on March 31, 2008, and days' sales outstanding for the first quarter of 2009 was 96 days. At June 30, 2008, the Company had stockholders' equity of $48.5 million.

Business Outlook

The Company's new bulk additives production facility remains scheduled to begin production in the Company's fiscal third quarter. As of June 30, 2008, China-Biotics had signed contracts with four business customers to supply those customers with bulk probiotics in powder form that can be added to products such as milk, ice cream, yogurt, baked goods and nutritional supplements.

The Company's retail strategy is also on schedule, with 83 Shining retail outlets open as of June 30, 2008, in Shanghai
'/>"/>

SOURCE China-Biotics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter 2009 Financial Results
2. China-Biotics, Inc. Files Application for Nasdaq Listing
3. China-Biotics, Inc. Announces Appointment of New Transfer Agent Effective August 15, 2008
4. China-Biotics, Inc. Reports Fourth Quarter and Full Year Fiscal 2008 Financial Results
5. China-Biotics, Inc. to Present at Chinas 3rd Annual Food Safety Technology Forum 2008
6. China-Biotics, Inc. Announces Conference Call to Discuss Fourth Quarter and Full Year 2008 Results
7. China-Biotics, Inc. to Supply Probiotics to Pharmaceutical Company
8. China-Biotics, Inc. to Present at Two Upcoming Investor Conferences
9. China-Biotics, Inc. Completes Foundation for Its New Plant
10. China-Biotics, Inc. Reports Third Quarter 2008 Financial Results
11. China-Biotics, Inc. Announces Rescheduling of Conference Call to Discuss Third Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... A study has been launched to test whether ... could help to tackle the problem of obesity.  This unique ... surgery based in Stowmarket) and academics at University Campus Suffolk ... technology, which is inspired by equipment used to collect data ...
(Date:1/15/2014)... The Microcompetition with Foreign DNA theory explains how ... latent viruses is the Epstein Barr Virus (EBV), and one ... is a chronic inflammatory disease that destroys the body’s joints. ... patients have high concentrations of EBV DNA in their bodies ...
(Date:1/15/2014)... Freeslate, Inc ., the leading provider of ... one of India’s top five pharmaceutical companies, has received ... for high throughput solid form screening. , Lupin, ... range of quality, affordable generic and branded formulations and ...
(Date:1/14/2014)... January 14, 2014 Date: Friday, April 11, ... Warrington Country Club, 1360 Almshouse Road, Warrington, Pa. ... organization solely dedicated to finding a cure for hepatitis B ... will host its annual Crystal Ball on Friday, April 11 ...
Breaking Biology Technology:Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2
... 7 BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) ... Corporate Development of BioMarin, will present a company update at ... 14, 2009 at 10:40 a.m. CT. Interested parties may ... the investor section of the BioMarin website, www.BMRN.com ...
... deCODE genetics, Inc.,(Nasdaq: DCGN ) today announced that it ... release to be issued on Monday, May 11, after,the close ... a live webcast of,its conference call to discuss these results ... Daylight Time/ 12pm GMT/1pm British Summer,Time. , ...
... (NYSE: CVD ) announced that it has ... McCartney currently serves as chairman of the board of ... and supply chain solutions. He was formerly president ... multibillion dollar provider of information access technologies. He was ...
Cached Biology Technology:BioMarin to Present at the Baird Growth Stock Conference 2deCODE genetics Announces Webcast of Conference Call to Discuss First Quarter 2009 Financial Results 2Covance Elects John McCartney to Company's Board of Directors 2
(Date:4/24/2014)... generation of military veterans returning home from Iraq and ... concern in American medical institutions and the culture at-large. ... personnel deployed to Iraq and Afghanistan suffer from PTSD. ... of Medicine is shedding light on how PTSD is ... , The rise in PTSD has implications beyond the ...
(Date:4/24/2014)... liquid can bend light, acting as a lens. Now, ... new process to create inexpensive high quality lenses that ... Because they,re so inexpensive, the lenses can be used ... diseases in the field, scientific research in the lab ... , "What I,m really excited about is that ...
(Date:4/23/2014)... satellite data shows Africa,s Congo rainforest, the second-largest tropical ... in greenness over the past decade. , The study, ... University of New York, shows between 2000 and 2012 ... and intensified. The research, published Wednesday in Nature ... to explore the effects of long-term drought on the ...
Breaking Biology News(10 mins):New study links inflammation in those with PTSD to changes in microRNA 2New study links inflammation in those with PTSD to changes in microRNA 3Bake your own droplet lens 2Bake your own droplet lens 3NASA satellites show drought may take toll on Congo rainforest 2NASA satellites show drought may take toll on Congo rainforest 3
... PHOENIX, Ariz. Feb. 2, 2009 A drug used ... improve learning and memory and reduce the risk of Alzheimer,s ... at the Translational Genomics Research Institute (TGen) and Arizona State ... years to help protect the brain in stroke patients by ...
... treatment, but it,s not always effective. Successful chemotherapy depends ... the bloodstream through the leaky blood vessels that often ... of individuals from unnecessary toxicity and the often difficult ... published in the February issue of the journal ...
... lab in India that stops tuberculosis in its tracks. In ... crucial metabolic pathways at the same time, weakening and ultimately ... will not work in humans. Not willing to set aside ... doors of pharmaceutical companies to see if he can get ...
Cached Biology News:TGen and ASU researchers find drug that could reduce risk of Alzheimer's 2TGen and ASU researchers find drug that could reduce risk of Alzheimer's 3New technique images tumor vessel leakiness to predict breast cancer chemotherapy outcome 2New technique images tumor vessel leakiness to predict breast cancer chemotherapy outcome 3In India: A search for more effective tuberculosis drugs 2In India: A search for more effective tuberculosis drugs 3
... Source: E. coli strain containing an ... M-MLV Reverse Transcriptase catalyzes the polymerization ... RNA:DNA hybrids(1). Full-length copies of large mRNAs, ... Transcriptase has a much lower RNase H ...
...
RNase-Free DNase 50 l...
... T7 RNA polymerase is a DNA-dependent ... T7 phage promoters. It efficiently synthesizes ... that is down stream from a T7 ... hybridization probes, templates for in vitro translation, ...
Biology Products: